Company Overview and News
With Australia predicted to be the leading LNG exporter by 2022, growth in the industry has been strong this year.
Comet Ridge Ltd (ASX:COI) is benefitting from an increasing gas flow rate from the Mira 6/2 vertical horizontal combination pilot well at its Mahalo Coal Seam Gas project in Queensland.
Santos, Origin and junior gas player Comet Ridge have boosted the NSW's Mahalo coal seam gas project's reserves by 473 per cent, making it one of the largest undeveloped gas projects on the east coast.
Vintage Energy Ltd (VEN) has met all conditions precedent for its farm - in to the Sandstone reservoir sequence within the Galilee Basin permits ATP743, ATP744, and ATP1015 (Galilee Permits) in Queensland from Comet Ridge Limited (COI).
As the oil and gas market braces for a rush in mergers and acquisitions, Australia’s recent forecast domestic gas shortage has done more than just raise concerns of an energy crisis, it also drew attention to a market ripe for takeover.
Vintage Energy Ltd Completes $5.3 Million Pre-IPO capital raising and satisfies major financial condition precedent for Galilee Basin farm-in.
Securing a contract with Singapore Telecommunications Limited (SGX:Z74) and its Australian subsidiary Singtel Optus Pty Ltd was the catalyst for Knosys increasing 118% to $0.12.
Comet Ridge Ltd’s (ASX:COI) increase in gas rates at the Mira pilot scheme in the Mahalo block in Queensland is also being eagerly watched by multinational players that make up the Australia Pacific LNG venture (APLNG).
Comet Ridge Ltd’s (ASX:COI) shares closed 9.5% higher on Tuesday after commencing gas production at its Mira wells in the Mahalo Block in central Queensland.
Comet Ridge Ltd's (ASX:COI) shares closed at $0.275 yesterday, around double their value from two months ago, and the company is taking the opportunity to head to market with a capital raising.
Ø Vintage Energy Pty Ltd executes agreement with Comet Ridge Ltd for Galilee Basin Sandstone Farm-in
Comet Ridge (ASX:COI) has successfully completed a $5.3 million placement to institutional investors at $0.125 per share to fund its gas exploration program in Queensland.
Comet Ridge (ASX:COI) has been granted a trading halt by the ASX, pending details of a capital raising.
Comet Ridge (ASX:COI) has been granted a trading halt by the ASX, pending an update on progress from the Mahalo Block in Queensland.
Comet Ridge Ltd (ASX:COI) plans to raise $2 million to progress its 40% owned Maholo coal seam gas project located in Queensland’s Bowen Basin. The raising will consist of a $1 million placement priced at $0.05, which will be followed by a 1:25 rights issue to raise up to an additional $1.05 million. Tor McCaul, managing director, commented: “The funds raised will be used for working capital while the company finalises the appraisal programme for reserves upgrade at Mahalo prior to commencing development, whilst also progressing funding discussions for drilling on the Albany Structure in the Eastern Galilee Basin.
20h - Asif
Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...
20h - Asif
Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...
2018-05-21 - Asif
Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...